Miscellaneous treatments, II: niacin and heparin: unapproved uses, dosages, or indications.
Wolf
Ronni
R
Dermatology Unit, Kaplan Medical Center, Rechovot, Israel. wolf_r@netvision.net.il
Orion
Edith
E
Matz
Hagit
H
Tüzün
Yalcin
Y
Tüzün
Binnur
B
D003879:Dermatologic Agents / Q000008:administration & dosage / Q000009:adverse effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D017277:Drug Approval; D004363:Drug Utilization; D005260:Female; D005500:Follow-Up Studies; D006493:Heparin / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D007557:Israel; D008297:Male; D009525:Niacin / Q000008:administration & dosage* / Q000009:adverse effects; D016032:Randomized Controlled Trials as Topic; D018570:Risk Assessment; D012871:Skin Diseases / Q000175:diagnosis / Q000188:drug therapy*; D016896:Treatment Outcome; D014421:Turkey
D003879:Dermatologic Agents; D009525:Niacin; D006493:Heparin